Pascal Soriot, AstraZeneca CEO, joins ‘Squawk on the Street’ to discuss why company data around its breast cancer drug was so well received, the next steps for other tumor types and more.
You May Also Like
About the Author: Chaz Cutler
My name is Chasity. I love to follow the stock market and financial news!